Ich stimme zu, dass diese Seite Cookies verwende. Weitere Informationen finden Sie unter unseren Datenschutzerklärungen .
X
Masih‐Khan, Esther
43  Ergebnisse:
Personensuche X
?
1

Outcome of carfilzomib/pomalidomide‐based regimens after da..:

LeBlanc, Richard ; Mian, Hira ; Reece, Donna...
European Journal of Haematology.  111 (2023)  5 - p. 815-823 , 2023
Link: https://doi.org/10.1111/..
 
?
2

Outcomes of daratumumab in the treatment of multiple myelom..:

LeBlanc, Richard ; Mian, Hira ; Reece, Donna...
British Journal of Haematology.  198 (2022)  1 - p. 93-102 , 2022
Link: https://doi.org/10.1111/..
 
?
3

Real‐world data on lenalidomide dosing and outcomes in pati..:

Mian, Hira ; LeBlanc, Richard ; Louzada, Martha...
Cancer Medicine.  12 (2022)  4 - p. 4357-4362 , 2022
Link: https://doi.org/10.1002/..
 
?
4

Carfilzomib usage patterns and outcomes in patients with re..:

McCurdy, Arleigh ; Louzada, Martha ; Venner, Christopher P....
eJHaem.  3 (2022)  4 - p. 1252-1261 , 2022
Link: https://doi.org/10.1002/..
 
?
5

Retrospective study of treatment patterns and outcomes post..:

Reece, Donna E. ; Masih‐Khan, Esther ; Atenafu, Ehetu G....
European Journal of Haematology.  107 (2021)  4 - p. 416-427 , 2021
Link: https://doi.org/10.1111/..
 
?
6

The impact of lenalidomide maintenance on second‐line chemo..:

Cherniawsky, Hannah M. ; Kukreti, Vishal ; Reece, Donna...
European Journal of Haematology.  106 (2021)  5 - p. 673-681 , 2021
Link: https://doi.org/10.1111/..
 
?
7

Real‐world outcomes with bortezomib‐containing regimens and..:

Jimenez‐Zepeda, Victor H. ; Venner, Christopher ; McCurdy, Arleigh...
British Journal of Haematology.  193 (2021)  3 - p. 532-541 , 2021
Link: https://doi.org/10.1111/..
 
?
8

Kinetics of response to first‐ and second‐line therapies in..:

Lebel, Eyal ; Li, Xuan ; Paul, Harminder...
European Journal of Haematology.  108 (2021)  3 - p. 204-211 , 2021
Link: https://doi.org/10.1111/..
 
?
9

Secondary primary malignancies during the lenalidomide–dexa..:

Kotchetkov, Rouslan ; Masih‐Khan, Esther ; Chu, Chia‐Min...
Cancer Medicine.  6 (2016)  1 - p. 3-11 , 2016
Link: https://doi.org/10.1002/..
 
?
10

Phase I‐II trial of oral cyclophosphamide, prednisone and l..:

Reece, Donna E. ; Masih‐Khan, Esther ; Atenafu, Eshetu G....
British Journal of Haematology.  168 (2014)  1 - p. 46-54 , 2014
Link: https://doi.org/10.1111/..
 
?
11

Efficacy of thalidomide‐based therapy following lenalidomid..:

Kukreti, Vishal ; Masih‐Khan, Esther ; Young, Trieu...
American Journal of Hematology.  88 (2013)  4 - p. 337-338 , 2013
Link: https://doi.org/10.1002/..
 
?
12

Central nervous system involvement with multiple myeloma: l..:

Chen, Christine I. ; Masih‐Khan, Esther ; Jiang, Haiyan...
British Journal of Haematology.  162 (2013)  4 - p. 483-488 , 2013
Link: https://doi.org/10.1111/..
 
?
13

Preclinical studies of fibroblast growth factor receptor 3 ..:

Paterson, Joshua L. ; Li, Zhihua ; Wen, Xiao‐Yan...
British Journal of Haematology.  124 (2004)  5 - p. 595-603 , 2004
Link: https://doi.org/10.1111/..
 
?
14

The Impact of CD34+ Cell Collection Yields for Autologous T..:

Lebel, Eyal ; Lajkosz, Katherine ; Masih-Khan, Esther...
Clinical Lymphoma Myeloma and Leukemia.  23 (2023)  11 - p. 850-856 , 2023
Link: https://doi.org/10.1016/..
 
?
15

Real-world results of autologous stem cell transplantation ..:

Côté, Julie ; LeBlanc, Richard ; Mian, Hira...
Blood Cancer Journal.  13 (2023)  1 - p. , 2023
Link: https://doi.org/10.1038/..
 
1-15